NewsAI-assisted

FDA Approves First Hearing Aid Software for Apple’s AirPods Pro

FDA approves hearing aid software for AirPods Pro, offering a new solution for mild hearing loss.

Mrudula Kulkarni
By Mrudula Kulkarni
Managing Editor - Pharma Now
Sep 13, 2024Updated Jun 26, 2025 · 2 min read
Share
FDA Approves First Hearing Aid Software for Apple’s AirPods Pro
https://9to5mac.com/2024/09/12/apple-just-got-approval-for-airpods-pro-2s-hearing-aid-feature/
AI-assisted reporting
Reviewed by Mrudula Kulkarni, Managing Editor - Pharma Now

The US Food and Drug Administration (FDA) has approved the first over-the-counter (OTC) hearing aid software for Apple’s AirPods Pro, enabling people with mild to moderate hearing loss to use the popular headphones as hearing aids. The software, known as the Hearing Aid Feature (HAF), can be accessed via a simple software update, making it easy for users to customise their AirPods Pro without professional assistance.

Designed for individuals 18 and older, the HAF is self-fitted using an iPhone or iPad through the iOS HealthKit, which gathers the user’s hearing data. This allows users to adjust volume, tone, and balance to match their preferences. In a study involving 118 participants, the HAF was shown to provide similar benefits to professionally fitted hearing aids, with no adverse events reported.

Approved under the FDA’s De Novo premarket review pathway, the HAF offers a new, accessible solution for hearing support. Michelle Tarver, Acting Director of the FDA Center for Devices and Radiological Health, stated that this approval marks a significant advancement in hearing aid accessibility.

Apple recently introduced additional features for its Apple Watch Series 10 and AirPods Pro 2 to enhance sleep and hearing health, further cementing its role in personal wellness.

 

TopicsNews
Mrudula Kulkarni
Written by
Mrudula Kulkarni
Managing Editor - Pharma Now

My international experience as a researcher in Taiwan for three years has equipped me with a global perspective, enabling me to create content that resonates with an international audience.



Discussion

Loading discussion…

More from Pharma News

All stories →